Vipergen Develops New Drug Discovery Technology Platform

Vipergen is a biotech start-up company founded in 2005 to commercialise a new, proprietary drug discovery technology platform.

Vipergen's technology platform allows isolation of high quality drug leads, small molecules or non-natural peptides from libraries with molecular diversity more than 10¹². This is achieved by performing molecular evolution in a test tube, thus mimicking the principle of survival of the fittest known from nature, with generations of selection and reproduction.

For further information please contact:

Nils Jakob Vest Hansen,

CEO

Tel: +45 39 17 97 98

Email: info@vipergen.com

Or visit: www.vipergen.com